Analytic validation of the enzyme multiplied immunoassay technique for thedetermination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay
H. Hosotsubo et al., Analytic validation of the enzyme multiplied immunoassay technique for thedetermination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay, THER DRUG M, 23(6), 2001, pp. 669-674
The analysis of mycophenolic acid (MPA) has proved a valuable adjunct to th
e clinical care of organ transplant recipients. The analytic validation of
the enzyme multiplied immunoassay technique (EMIT) for the determination of
MPA in plasma is described. The EMIT MPA standard curve was 0 to 15.0 mug/
mL, and curve storage was maintained for 4 weeks. The MPA EMIT assay proved
reliable and reproducible, as shown by the intra-assay and interassay coef
ficients of variation (1.58-3.68% and 1.23-7.57%, respectively). Excellent
linear correlation (r = 0.999) was observed for dilution linearity. The sen
sitivity of the assay was 0.01 mug/mL. Recoveries of 99.4% to 104.29% were
obtained by spiking aliquots of three controls of known MPA concentrations
with MPA. No interference was observed for endogenous substances and coadmi
nistered immunosuppressant drugs, and no cross-reactivity from the major me
tabolite MPA glucuronide was found. The high-performance liquid chromatogra
phy (HPLC) assay used protein precipitation and C18 ion-pair chromatography
with ultraviolet detection at 304 nm. Plasma concentrations of MPA were me
asured using EMIT and HPLC. A linear relationship was observed between EMIT
and HPLC (EMIT = 1.091 x HPLC - 0.089; r(2) = 0.990, n = 129). These resul
ts indicate that EMIT is a simple, rapid, and sensitive assay method for th
e measurement of MPA in plasma.